RIT Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$278M |
| 2 |
Stryker
SYK
|
+$23.6M |
| 3 |
Boston Scientific
BSX
|
+$21.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$23.1M |
| 2 |
Trane Technologies
TT
|
+$21.7M |
| 3 |
Texas Instruments
TXN
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 48.35% |
| 2 | Financials | 19.23% |
| 3 | Consumer Discretionary | 13.92% |
| 4 | Miscellaneous | 8.51% |
| 5 | Healthcare | 6.46% |
No holdings matched the selected filter criteria.
Similar funds
RIT Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, RIT Capital Partners held 15 positions worth $621M, up 66% from $374M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
RIT Capital Partners deployed $262M of net new capital in Q2 2026, opening 3 new positions. Its largest new stake was SpaceX: 1,634,820 shares worth $279M.
By sector, the portfolio is most concentrated in Industrials at 48% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $23.1M trimmed.
- RIT Capital Partners's largest Q2 2026 buy was SpaceX: 1,634,820 shares worth $279M.
- RIT Capital Partners's biggest Q2 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $23.1M.
- RIT Capital Partners fully exited Trane Technologies in Q2 2026, selling an estimated $21.7M.
- RIT Capital Partners's ten largest holdings make up 91% of its $621M portfolio in Q2 2026.
- RIT Capital Partners opened 3 new positions and closed 2 in Q2 2026.
- RIT Capital Partners's portfolio value rose 66% quarter-over-quarter to $621M.
Based on RIT Capital Partners's 13F filing for Q2 2026, filed 11 Aug 2026.